亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Rituximab and Bendamustine for CNS Involvement by Chronic Lymphocytic Leukemia (P7.261)

作者
Géraldine Faivre,Samuel Singer,Lisa M. DeAngelis,Ariela Noy,Antonio Omuro
出处
期刊:Neurology [Lippincott Williams & Wilkins]
卷期号:82 (10_supplement) 被引量:5
标识
DOI:10.1212/wnl.82.10_supplement.p7.261
摘要

OBJECTIVE: To report outcomes in patients with chronic lymphocytic leukemia (CLL) presenting with CNS and leptomeningeal involvement (CNS CLL) treated with intravenous (IV) rituximab and bendamustine (R-benda). BACKGROUND: Chronic Lymphocytic Leukemia (CLL) is a hematologic malignancy characterized by small mature and malignant B lymphocyte proliferation. Autopsy studies have demonstrated CNS involvement in 8-12% of patients, usually as leptomeningeal disease (LMD), or more rarely as parenchymal involvement, though presentations with clinical symptoms are rare. This likely reflects transformation to diffuse large B cell lymphoma in the majority of cases. The prognosis of CNS CLL is poor, with an average survival of 12 months and no standard treatment. R-benda is a highly effective regimen in CLL, but penetration through the blood-brain barrier is suboptimal, and the use of this regimen to treat CNS CLL has not been reported. DESIGN/METHODS: Institutional databases were searched to identify patients with CNS involvement by CLL that were treated with R-Benda. RESULTS: Three patients met the inclusion criteria. The first (#1) was a 55 year-old man with optic neuropathy and thoracic myelopathy, with a clinical presentation resembling multiple sclerosis. Neuroimaging showed periventricular and spinal cord lesions. The second (#2) was a 53-year-old woman presenting with seizures and a left frontal lesion. The third (#3) was a 73 year-old woman presenting with thoracic and lumbar multi-radiculopathy. All patients had pleocytosis and CSF involvement by CLL, confirmed by flow cytometry or gene rearrangement studies. Patients received 5-6 cycles of R-benda, which were well tolerated and resulted in a complete response in all, as measured by follow up imaging and CSF analysis. The progression-free survival from diagnosis was 20 months for patient #1, 44+ months for #2 and 8+ months for #3. The overall survival was 42 months (#1), 47+ months (#2) and 8+ months (#3). CONCLUSIONS: In this selected group of patients with CNS CLL, the R-benda regimen was safe and efficacious, warranting further investigation. Study Supported by: NA

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
elfriede完成签到 ,获得积分10
8秒前
10秒前
12秒前
13秒前
123发布了新的文献求助10
14秒前
小蘑菇的应助被biubiu采纳,获得10
18秒前
懵懂的念波完成签到,获得积分10
19秒前
英俊的铭的应助被123采纳,获得10
22秒前
28秒前
领导范儿的应助被晚风采纳,获得10
31秒前
33秒前
DDDL发布了新的文献求助10
34秒前
leo发布了新的文献求助10
36秒前
40秒前
41秒前
晚风发布了新的文献求助10
45秒前
CAOHOU的应助被白华苍松采纳,获得10
45秒前
萧雨墨发布了新的文献求助10
46秒前
49秒前
49秒前
50秒前
fantasy的应助被科研通管家采纳,获得10
50秒前
56秒前
leo完成签到,获得积分10
59秒前
1分钟前
amiee发布了新的文献求助10
1分钟前
1分钟前
wuyp发布了新的文献求助10
1分钟前
善良的金鱼完成签到,获得积分10
1分钟前
慕青的应助被踏实的聪健采纳,获得10
1分钟前
1分钟前
所所的应助被amiee采纳,获得10
1分钟前
1分钟前
苗苗发布了新的文献求助10
1分钟前
Orange的应助被Balloon采纳,获得10
1分钟前
1分钟前
高速公鹿完成签到 ,获得积分10
1分钟前
一只不受管束的小狸Miao完成签到 ,获得积分10
1分钟前
可爱的函函的应助被cjhsci采纳,获得10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190078
求助须知:如何正确求助?哪些是违规求助? 9577216
关于积分的说明 21851985
捐赠科研通 7788239
什么是DOI,文献DOI怎么找? 3436236
关于科研通互助平台的介绍 2559951
邀请新用户注册赠送积分活动 2482818